Artículos del autor

solaci

Structural heart disease

The SOURCE 3 Confirms the Good Outcomes of the SAPIEN 3 at One Year Followup

Transcatheter aortic valve replacement (TAVR) was developed as a strategy to treat non-surgical aortic stenosis, and was later...
solaci -
Institutional News

SOLACI-SOCIME 2018: Ciudad de Mexico is waiting for us

We are thrilled to announce that the date for the next SOLACI-SOCIME Congress has been confirmed! We...
solaci -
Structural heart disease

New Study Confirms TAVR Durability at 5 Years

The ADVANCE study was designed to evaluate the safety and effectiveness of transcatheter aortic valve replacement (TAVR)...
solaci -
Coronary disease

2.0-mm DES for Very Small Vessels: Are They Viable?

The reference vessel diameter is a fundamental factor for restenosis after coronary angioplasty even with drug-eluting stents....
solaci -
Institutional News

SOLACI Symposium at TCT 2017

Next Sunday, October 29, one of the most important cardiology meetings starts in Denver, Colorado: the TCT...
solaci -
Coronary disease

Effects of Cerebral Radiation on Interventional Cardiologists

In recent years, there has been a growing concern about the occupational hazard for interventional cardiologists who...
solaci -
Coronary disease

Excellent Outcomes for the First Sirolimus Eluting Balloon Tested on Instent Restesosis

Much has been done since studies on conventional balloon angioplasty for BMS instent restenosis showed over 40% new revascularization.  Drug...
solaci -
Peripheral vascular disease

An Important Study Shows That Renal Function Must Be Cared for in TAVR

Courtesy of Dr. Carlos Fava. The presence of renal dysfunction in the “real world” is over 25% in patients...
solaci -